CytoSPAR specializes in using the power of advanced science to transform disease management with simplified diagnostic solutions. A flagship technology, blAST, uses direct sample phenotypic antimicrobial susceptibility testing (AST) to accelerate the process of identifying effective antimicrobial agents while reducing the time-to-results from days to mere hours.  This rapid turnaround is crucial in the fight against antimicrobial resistance (AMR), ensuring patients a more timely and effective treatment. 

Visit our website to learn how CytoSPAR is developing solutions to diagnostic dilemmas.

CytoSPAR

Jack Davis

This department provides strategic direction and oversight for the organization's overall operations and vision.

CytoSPAR

Org chart

Teams

Executive Leadership

Offices

CytoSPAR

Org chart

Teams

Executive Leadership

Offices

Related companies